Dr. Cavazzoni has been interim director since spring 2020.
“Having spent most of my career with CDER, I have a deep appreciation of the role. Dr. Cavazzoni’s credentials are of the highest caliber, and I know she will continue to excel in advancing the FDA’s public health mission for the benefit of all,” Dr. Woodcock stated.
Dr. Cavazzoni joined the FDA in 2018 to serve as deputy director for operations at the Center for Drug Evaluation and Research. She was also the acting principal deputy commissioner of food and drugs in early 2019.
More articles on leadership and management:
How health systems are using employee feedback to bounce back from pandemic
American Hospital Association kicks off $1M health equity initiative
Arizona health system removes Chinese dragon sculpture after backlash from Asian community
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.